You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

European Journal of Ophthalmology

Impact Factor: 1.4 / 5-Year Impact Factor: 1.7

Journal Homepage Submission guidelines

Restricted access

Research article

First published online 2017-5

Author's Reply to Comments to: Clinical Experience of Switching Anti-VEGF Therapy from Ranimizumab to Aflibercept in Age-Related Choroidal Neovascularization

Volume 27, Issue 3

https://doi.org/10.5301/ejo.5000931

Abstract

Get full access to this article

View all access options for this article.

References

1.

Van Lancker

L

et al.

Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.

Eur J Ophthalmol 2016 Oct 3 doi: 10.5301/ejo.5000861. [Epub ahead of print].

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Comparison of three strategies (urgent vs. early vs. planned-start) of peritoneal dialysis initiation in kidney failure patients requiring dialysis

Free access

Environmental Influences on Development of Type 2 Diabetes and Obesity: Challenges in Personalizing Prevention and Management

Free access

Case Report: Anaesthesia in Myotonic Dystrophy

Free access

Increases in Oxygen Consumption without Cerebral Blood Volume Change during Visual Stimulation under Hypotension Condition